Descriptor English: | Dihydrotestosterone | ||||||
Descriptor Spanish: |
Dihidrotestosterona
| ||||||
Descriptor Portuguese: | Di-Hidrotestosterona | ||||||
Descriptor French: | 5alpha-Dihydrotestostérone | ||||||
Entry term(s): |
17 beta Hydroxy 5 beta Androstan 3 One 17 beta-Hydroxy-5 beta-Androstan-3-One 17beta Hydroxy 5alpha Androstan 3 One 17beta-Hydroxy-5alpha-Androstan-3-One 5 alpha DHT 5 alpha Dihydrotestosterone 5 alpha-Dihydrotestosterone 5 beta Dihydrotestosterone 5 beta-Dihydrotestosterone 5-alpha Dihydrotestosterone 5-alpha-DHT Anaprotin Andractim Androstanolone Dihydroepitestosterone Dihydrotestosterone, 5-alpha Gelovit Stanolone beta-Hydroxy-5 beta-Androstan-3-One, 17 |
||||||
Tree number(s): |
D04.210.500.054.040.248 D06.472.334.851.968.964 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D013196 | ||||||
Scope note: | A potent androgenic metabolite of TESTOSTERONE. It is produced by the action of the enzyme 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Androgens |
||||||
Registry Number: | 08J2K08A3Y | ||||||
CAS Type 1 Name: | Androstan-3-one, 17-hydroxy-, (5alpha,17beta)- | ||||||
Public MeSH Note: | 2004; see STANOLONE 1963-2003 |
||||||
History Note: | 2004 (1963) |
||||||
DeCS ID: | 13583 | ||||||
Unique ID: | D013196 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2004/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds
|
Dihydrotestosterone
- Preferred
5 beta-Dihydrotestosterone
- Related but not broader or narrower
Gelovit
- Narrower
Andractim
- Narrower
Dihydroepitestosterone
- Related but not broader or narrower
17 beta-Hydroxy-5 beta-Androstan-3-One
- Related but not broader or narrower
Anaprotin
- Narrower
Concept UI |
M0020414 |
Scope note | A potent androgenic metabolite of TESTOSTERONE. It is produced by the action of the enzyme 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE. |
Preferred term | Dihydrotestosterone |
Entry term(s) |
17beta Hydroxy 5alpha Androstan 3 One 17beta-Hydroxy-5alpha-Androstan-3-One 5 alpha DHT 5 alpha Dihydrotestosterone 5 alpha-Dihydrotestosterone 5-alpha Dihydrotestosterone 5-alpha-DHT Androstanolone Dihydrotestosterone, 5-alpha Stanolone |
Concept UI |
M0020413 |
Preferred term | 5 beta-Dihydrotestosterone |
Entry term(s) |
5 beta Dihydrotestosterone |
Concept UI |
M0433953 |
Preferred term | Gelovit |
Concept UI |
M0433952 |
Preferred term | Andractim |
Concept UI |
M0442745 |
Preferred term | Dihydroepitestosterone |
Concept UI |
M0020412 |
Preferred term | 17 beta-Hydroxy-5 beta-Androstan-3-One |
Entry term(s) |
17 beta Hydroxy 5 beta Androstan 3 One beta-Hydroxy-5 beta-Androstan-3-One, 17 |
Concept UI |
M0433951 |
Preferred term | Anaprotin |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey